Novartis US
@NovartisUS
Followers
3K
Following
93
Media
105
Statuses
384
An innovative medicines company working to reimagine medicine. See our community guidelines: https://t.co/NHpARWg6Vn.
United States
Joined March 2020
#News: We are excited to share our new label update for first-line use of our low-density lipoprotein cholesterol (LDL-C) treatment. This update now offers us the potential to help even more patients reach their LDL-C lowering goals earlier in their cholesterol management
0
1
2
The NYSE welcomes @ZEROCancer & @Novartis to celebrate Blitz the Barriers—which aims to be the most ambitious prostate cancer initiative in U.S. history, with a goal of saving 100,000 lives by 2035. $NVS
5
9
18
Together with @ZEROCancer and partners, we are sounding the bell to break down barriers in #ProstateCancer. Today, we joined the opening ceremony at the @NYSE to introduce real change for men’s health. 🎉 Learn more about Blitz The Barriers: https://t.co/LJ14odns7r
#NYSE
0
0
2
#News: Phase III PSMAddition trial demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer.
1
2
10
#NEWS: We are sharing a new sub-analysis of data on patients with HR+/HER2- early #breastcancer across various ages, including younger patients. Learn more: https://t.co/4h18vB01uX
#NovartisUS #ASCO25 #BCSM
3
1
0
From reimagining the impossible to forging partnerships that make us unstoppable as a community, see how we are #ReimaginingMedicine, together.​ Learn more: https://t.co/C184PXEct2
#NovartisUS
1
0
1
As a local sponsor of @LLSusa #BloodCancer Conferences, we're grateful to partner with a group whose commitment to the blood cancer community mirrors our own, especially in empowering people living with chronic myeloid leukemia to speak up about their treatment journeys.
0
0
3
#News: We’re excited to announce our upcoming oncology and hematology data that has been recently accepted at @ASCO Annual Meeting and @EHA_Hematology 2025 Congress. https://t.co/hOgJfeVb81
#ASCO25 #EHA2025
0
0
4
As a member of @BCpolicyNOW, we’re raising awareness about the need to remove barriers to #breastcancer care through policies like the Access for Breast Cancer Diagnosis (ABCD) Act. Now we need to get Congress’s attention: https://t.co/ZAWpmObTvl
#ReimaginingMedicine
@KomenAdvocacy @NovartisUS @elaine1walsh "The #ABCDAct is so essential because we have a problem: access to diagnosis is not guaranteed. Not because tests don’t exist, or doctors don’t care. It’s because patients can't afford." @ACSCAN's Angela Sailor explains how the ABCD Act could help address the access issue for
3
0
1
#News: We are expanding our US-based manufacturing and R&D footprint with a planned $23B investment over the next 5 years. đź”— https://t.co/jGBfesZqhb
#NovartisUS
5
7
10
Today’s regulatory milestone represents a step forward for patients, loved ones and providers who have been in need of more options to treat advanced prostate cancer earlier. https://t.co/rnjCkXUxs7
#NovartisUS #ReimaginingMedicine
1
2
6
We are joining the roster as the @NFL’s first-ever corporate pharmaceutical partner! This collaboration is designed to bring critical health conversations to the forefront, making preventive care and early detection more accessible for fans everywhere. 🤝
2
2
8
Partnering with @SusanGKomen and other leading advocacy voices to launch the Alliance for Breast Cancer Policy is a testament to our collective commitment to improving outcomes for people affected by #breastcancer. @BCpolicyNOW
1
0
4
Novartis highlights commitment to hidradenitis suppurativa and chronic spontaneous urticaria at AAAAI and AAD annual congresses. https://t.co/G4NLszL7IH
0
1
4
Partnering with @ZEROCancer is a demonstration of our deep commitment to closing gaps faced by people with #prostatecancer and supporting better health care. #ReimaginingMedicine
1
0
1
Today, we are proud to announce our role as Lead Founding Partner of @ZEROCancer's Blitz The Barriers. Together, we’ll improve outcomes among populations who are greatly impacted by #prostatecancer. #ReimaginingMedicine
0
1
3